期刊文献+

维持性血液透析患者血清vaspin水平与胰岛素抵抗的相关性研究 被引量:3

Relationship between serum level of vaspin and insulin resistance in maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨维持性血液透析患者血清vaspin的水平及其与胰岛素抵抗的关系。方法选取我院透析中心终末期肾病维持性血液透析患者48例,测定血脂、尿素氮(BUN)、肌酐(Cr)、尿酸(UA)等指标,并抽血测定血清vaspin、血清胰岛素(FIns)、血糖(FBG),计算胰岛素敏感指数(ISI)、胰岛素抵抗指数(HOMA-IR)及腰臀比(WHR)、体质量指数(BMI),根据是否有糖尿病分为糖尿病组18例和非糖尿病组30例,同时选取30例健康体检者作为对照组,并对相关数据进行统计分析。结果①维持性血液透析患者血清vaspin水平较正常对照组降低,(0.91±0.36)μg/L vs(1.15±0.31)μg/L(P<0.01)。②糖尿病组和非糖尿病组两组患者的血清vaspin水平差异无统计学意义,(0.87±0.38)μg/L vs(0.97±0.34)μg/L(P>0.05)。③相关分析显示:vaspin除与BUN、Cr、UA、WHR相关外,尚与性别有关(r=-0.294、-0.284、-0.278、-0.375、0.244,P<0.05),其中,女性vaspin水平高于男性(1.11±0.38)μg/L vs(0.93±0.33)μg/L(P<0.05)。vaspin与HOMA-IR、FIns、FBG、年龄、BMI则没有相关性(r=-0.098,-0.146,0.049,-0.095、-0.182,P>0.05)。结论在维持性血液透析中存在有糖脂代谢紊乱和胰岛素抵抗,血清vaspin水平下降,与肾功能相关,但与胰岛素抵抗不相关。 Objective To investigate the level of serum vaspin in the maintenance hemodialysis patients and the relationship between vaspin level and insulin resistance. Methods 48 patients with end-stage renal disease (including 18 cases of diabetes and 30 cases of non-diabetes mellitus) were involved in this study, and 30 cases of normal healthy volunteers served as the control group. Serum vaspin was detected in three groups together with the following aspects: triglycerides, total cholesterol, high density lipoprotein-chdesterol, low-density lipoprotein-chdesterol, total protein, albumin, serum insulin, and fasting blood glucose(FBG), isulin sensitivity index, insulin resistance index, waist-to-hip ratio(WHR) and body mass index(BMI) were calculated and analyzed. Results (1)The level of serum vaspin in maintenance hemodialysis patients was lower than that of normal group, (0. 91± 0. 36) μg/L vs (1.15 ± 0.31 ) μg/L( P 〈 0.01). (2)There was no statistically significant difference in serum vaspin level between diabetes group and non-diabetes group,(0.87±0.38) μg/L vs (0.97±0.34) μg/L. (3) Correlation analysis shows that serum vaspin was not only correlated with urea nitrogen, creatinine, uric acid, WHR, but also with gender, the former correlation coefficients were -0. 294, - 0. 284, -0. 278 and -0. 375, the latter 0. 244 ( P G0.05), serum vaspin level in females was higher than in males (1.11±0.38) μg/L vs (0.93±0.33)μg/L( P 〈0.05),but it was not correlated with insulin resistance index and serum insulin,fasting blood glucose,age and BMI( r =-0. 098,-0. 146,0. 049,-0. 095,-0. 182, P〉0.05). Conclusion Glucose,lipid metabolism disorders and insulin resistance exist in maintenance hemodialysis patients. The lower level of serum vaspin is correlated with renal function,but it is not correlated with insulin resistance index.
出处 《临床荟萃》 CAS 2012年第24期2138-2141,共4页 Clinical Focus
关键词 糖尿病 肾透析 血清vaspin 胰岛素抵抗 diabetes mellitus renal dialysis serum vaspin insulin resistance
  • 相关文献

参考文献13

  • 1Greenfield JR,Campbell LV. Insulin resistance and obesity[J]. Clin Dermatol,2004,22(4) :289-295.
  • 2Lazar MA. How obesity causes diabetes: not a tall tale[J]. Science, 2005,307 (5708) : 373-375.
  • 3Kawano K, Hirashima T, Mori S, et al. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long- Evans Tokushima Fatty (OLETF) strain[J].Diabetes, 1992, 41(11) :1422-1428.
  • 4Hida K, Wada J, Zhang H, et al. Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats[J]. J Lipid Res,2000,41 (10):1615-1622.
  • 5Tan BK, Heutling D, Chen J, et al. Metformin decreases the adipokine vaspin in overweight women with polyeystie ovary syndrome concomitant with improvement in insulin sensitivityand a decrease in insulin resistance[J]. Diabetes, 2008,57 (6) : 1501-1507.
  • 6Hida K,Wada J, Eguehi J, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin sensitizing adipocytokine in obesity[J]. Proe Natl Acad Sci USA,2005,102 (30) : 10610-10615.
  • 7Cheung AK, Samak MJ, Yan S, et al. Cardian disease in maintenance hemdialysis patients: results of the HEMO study [J]. Kindney Int, 2004,65(6) : 2380-2389.
  • 8Matsuzawa Y. Adiponection, physiology and clinical relevance in metabolic and vascular disease [J]. Atherosclerosis supplements, 2005,6 (2) :7-14.
  • 9Snehalatha C, Ramachandran A, Satyavani K, et al. Plasma leptin is not associated with insulin resistance and proinsulin in non-diabetic South Asian Indians[J]. Diabet Med, 1998,15(6) 480-484.
  • 10孙倩美,沈洋,彭立人.左旋肉碱对维持性血液透析患者胰岛素抵抗的影响[J].中国血液净化,2005,4(2):77-78. 被引量:8

二级参考文献7

  • 1Mak RHK. Carbohydrate metabolism in uremia. P ediatr Nephrol, 1989,3:201-208
  • 2Ali I, Gunal, Huseyin C. the effect of L - carnitine on insulin resistance in hemodialysed patients with chronic renal failue. J of Nephrol, 1999,12(1):38-40
  • 3Borum PR, Taggard EM. Carnitine nutriture of dialysis patients. J Am Diet Assoc, 1986, 86(5) :644-7
  • 4Bouffard Y, Tissot S, Delafosse B, etal. Metabolic effects of hemodialysis with and without glucose in the dialysate. Kidney Int, 1993, 43:1086- 1090
  • 5Roden M, Price TB, Perseghin G, etal. Mechanism offree fatty acidinduced insulin resistance in humans. J Clin Invest, 1996, 97 (12):2859 - 2865
  • 6Maeda K, Shinzato T, Kobayakawa H. Effects of L- carnitine administration on short chain fatty acids (acetic acid) and long- chain fatty acid metabolism during hemodialysis. Nephron, 1989, 51 (3): 355- 361
  • 7Kautzky- Willer A, Pacini C, Barnas U, et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int, 1995, 47:200 - 206

共引文献7

同被引文献26

  • 1章建梁,秦永文,郑兴,郑国龙,刘明,赵仙先,陈少萍,郭冀珍.长期合用福辛普利和吲哚帕胺对高血压患者胰岛素抵抗及糖耐量的影响[J].中华全科医师杂志,2004,3(6):361-365. 被引量:5
  • 2Kobayashi S, Maejima S, Ikeda T, et al. Impact ofdialyBi8tllempyon insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis[J]. Nephrol Dial Transplant, 2000, 15(10): 65-70.
  • 3Furuhashi lit, Ura N, Takizawa H, et a l. Blockade of the renin-agiotensin system decreases adipocyte size with improvement in insulin sensitivity[J]. J Hypertens, 2004, 22 (10) : 1977-1982.
  • 4Jian W, Peng W, Xiao S, et al. Role of serum vaspin in progression o: type 2 diabetes:a 2-year cohort studyEJ].PLoS One,2014,9(4) :e94763.
  • 5EI-Mesallamy HO,Kassem DH,EI-Demerdash E,et al.Vspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus EJ].Metabolism, 2011,60(1) : 63-- 70.
  • 6Mm WQ,Fan J,Khor S et al.Serum vaspin levels and vaspin mRNA expression in subcutaneous adipose tissue in women with gestational diabetes mellitus[J]. Eur J Obstet Gynecol Reprod Biol, 2014,182 : 98-- 101.
  • 7Feng R,Li Y, Wang C, et al. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitusta recta-analysis[J]. Diabetes Res Clin Praet, 2014,106 (1) : 88-- 94.
  • 8Yilmaz Y, Kurt R, Gurdal A, et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease[J]. Atherosclerosis, 2011,217 ( 1 ) : 125 -- 129.
  • 9Aktas B, Yilmaz Y, Eren F, et al. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease[J]. Metabolism, 2011,60 (4) : 544 -- 549.
  • 10Li K, 1.i I:, Yang M, et al.Sbort-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity[J].Eur J Endocrinol, 2011, 164 (6) 905--910.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部